These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10811119

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC, Kaufmann SH.
    Cancer Res; 1997 Aug 15; 57(16):3375-80. PubMed ID: 9269999
    [Abstract] [Full Text] [Related]

  • 4. Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells.
    Bible KC, Kaufmann SH.
    Cancer Res; 1996 Nov 01; 56(21):4856-61. PubMed ID: 8895733
    [Abstract] [Full Text] [Related]

  • 5. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C, Motwani M, Kortmansky J, Sirotnak FM, She Y, Gonen M, Haimovitz-Friedman A, Schwartz GK.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Kaiser A, Nishi K, Gorin FA, Walsh DA, Bradbury EM, Schnier JB.
    Arch Biochem Biophys; 2001 Feb 15; 386(2):179-87. PubMed ID: 11368340
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
    Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L.
    Radiother Oncol; 2006 Aug 15; 80(2):185-91. PubMed ID: 16905211
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol.
    de Azevedo WF, Canduri F, da Silveira NJ.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):566-71. PubMed ID: 12054639
    [Abstract] [Full Text] [Related]

  • 17. Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
    Innocenti F, Stadler WM, Iyer L, Ramírez J, Vokes EE, Ratain MJ.
    Clin Cancer Res; 2000 Sep 26; 6(9):3400-5. PubMed ID: 10999721
    [Abstract] [Full Text] [Related]

  • 18. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
    Mason KA, Hunter NR, Raju U, Ariga H, Husain A, Valdecanas D, Neal R, Ang KK, Milas L.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1181-9. PubMed ID: 15234054
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y, Shen K, Tang PP.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 15; 42(11):761-4. PubMed ID: 18307904
    [Abstract] [Full Text] [Related]

  • 20. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S.
    Cancer Res; 2003 Feb 01; 63(3):621-6. PubMed ID: 12566305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.